Most read article(s)

Open Access
Efficacy of Vesicular Monoamine Transporter 2 Inhibition and Synergy with Antipsychotics in Animal Models of Schizophrenia
Samuel R. J. Hoare, Andrea E. Kudwa, Rosa Luo and Dimitri E. Grigoriadis

Journal of Pharmacology and Experimental Therapeutics May 2022, 381 (2) 79-95; DOI: https://doi.org/10.1124/jpet.121.000979
Open Access
Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity
Jaromir Vlach, Andrew T. Bender, Melinda Przetak, Albertina Pereira, Aditee Deshpande, Theresa L. Johnson, Sonja Reissig, Evgeni Tzvetkov, Djordje Musil, Noune Tahmassian Morse, Philipp Haselmayer, Simone C. Zimmerli, Shinji L. Okitsu, Robert L. Walsky and Brian Sherer

Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 397-409; DOI: https://doi.org/10.1124/jpet.120.000275
Open Access
Preclinical Immunopharmacologic Assessment of KPL-404, a Novel, Humanized, Non-Depleting Antagonistic Anti-CD40 Monoclonal Antibody
Sujatha Muralidharan, Moses Njenga, Tracy Garron, Kent Bondensgaard and John F. Paolini

Journal of Pharmacology and Experimental Therapeutics April 2022, 381 (1) 12-21; DOI: https://doi.org/10.1124/jpet.121.000881
Open Access
Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility
Nobuyuki Takahashi and Yukinori Take

Journal of Pharmacology and Experimental Therapeutics February 2018, 364 (2) 275-286; DOI: https://doi.org/10.1124/jpet.117.244202
You have access
Oxidative Stress and the Central Nervous System
Samina Salim

Journal of Pharmacology and Experimental Therapeutics January 2017, 360 (1) 201-205; DOI: https://doi.org/10.1124/jpet.116.237503
You have access
The Opioid Crisis and the Future of Addiction and Pain Therapeutics
Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
You have access
Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis
Randy Torralva and Aaron Janowsky

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 453-475; DOI: https://doi.org/10.1124/jpet.119.258566
Open Access
Drug Discovery Strategies for SARS-CoV-2
Zeenat A. Shyr, Kirill Gorshkov, Catherine Z. Chen and Wei Zheng

Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 127-138; DOI: https://doi.org/10.1124/jpet.120.000123
You have access
Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment
Anna Moszczynska and Sean Patrick Callan

Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 474-488; DOI: https://doi.org/10.1124/jpet.116.238501
Open Access
Resveratrol Attenuates High-Fat Diet–Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression
Weigang Yuan, Mi Zhang, Chunxu Wang, Bin Li, Lei Li, Feng Ye and Chuanrui Xu

Journal of Pharmacology and Experimental Therapeutics May 2022, 381 (2) 96-105; DOI: https://doi.org/10.1124/jpet.121.001018

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals